Mitchell H. Finer

Mitch Finer has been instrumental in founding, building and leading a number of MPM portfolio companies as an Executive Partner. Currently CSO of ElevateBio and President of ElevateBio BaseCamp, he is the founder and former CEO of Oncorus, focused on the development of best-in-class oncolytic virus therapies for both local and systemic administration. He is also a founder and the former CEO of CODA Biotherapeutics. Mitch serves on several MPM portfolio company boards, including CODA, ElevateBio, Oncorus, Semma Therapeutics and TCR2 Therapeutics.

He received his PhD in biochemistry and molecular biology from Harvard University and a BS in biochemistry and microbiology from UC, Berkeley. He completed a post-doctoral fellowship at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology (MIT).